Form 4: HPE Executive Sells Shares, Accrues RSU Dividends
Insider Transaction Report
Hewlett Packard Enterprise executive Maeve C. Culloty sold 3,738 shares of common stock and accrued dividend equivalent rights on her restricted stock units.
Summary
- Maeve C. Culloty, EVP, President & CEO Financial Services at Hewlett Packard Enterprise Co (HPE), reported a sale of common stock and accrual of dividend equivalent rights on Restricted Stock Units (RSUs).
- On September 23, 2025, 3,738 shares of HPE common stock were sold at a price of $25.12 per share.
- Following this transaction, direct beneficial ownership of common stock is 0 shares, with 27.234 shares held indirectly through Vanguard.
- On July 17, 2025, dividend equivalent rights were credited to her RSU accounts, specifically 19.1599 units from a 2022 grant, 70.9851 units from a 2023 grant, and 742.6539 units from a 2024 grant, each at $20.83 per RSU.
- Total beneficially owned RSUs after these credits are 3,307.5688, 11,923.8101, and 121,421.2226 units for the respective grants.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions, including a sale of a relatively small number of shares and the accrual of dividend equivalent rights on RSUs, which are standard components of executive compensation. There is no significant positive or negative news to alter the overall sentiment.
Positives
- Accrual of 832.7989 dividend equivalent rights on Restricted Stock Units (RSUs) indicates ongoing value generation from executive compensation plans.
- The dividend equivalent rights were credited at $20.83 per RSU, adding to the executive's beneficial ownership of derivative securities.
Negatives
- Sale of 3,738 shares of common stock by a key executive, Maeve C. Culloty, at $25.12 per share.
- The direct beneficial ownership of common stock following the reported transaction is 0 shares, indicating a full divestment of directly held common stock.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The sale of a relatively small number of shares by an executive is a routine insider transaction and is unlikely to have a significant impact on the company's stock price or investor sentiment. The accrual of dividend equivalent rights on RSUs is a standard part of executive compensation, reflecting ongoing equity incentives.
Next Steps
- Vesting of 3,070 RSUs from the 12/08/2022 grant on 12/08/2025.
- Vesting of 5,687 RSUs from the 12/07/2023 grant on 12/07/2025.
- Vesting of 39,665 RSUs from the 12/09/2024 grant on 12/09/2025.
- Further vesting of 5,687 RSUs from the 12/07/2023 grant on 12/07/2026.
- Further vesting of 39,665 RSUs from the 12/09/2024 grant on 12/09/2026.
- Further vesting of 39,666 RSUs from the 12/09/2024 grant on 12/09/2027.
Key Dates
| Date | Description |
|---|---|
| 12/08/2022 | Date of initial grant of 9,208 Restricted Stock Units (RSUs) to the reporting person. |
| 12/07/2023 | Date of initial grant of 17,060 Restricted Stock Units (RSUs) to the reporting person. |
| 12/09/2024 | Date of initial grant of 118,996 Restricted Stock Units (RSUs) to the reporting person. |
| 07/17/2025 | Dividend equivalent rights credited to the reporting person's RSU accounts. |
| 09/23/2025 | Transaction date for the sale of common stock by the reporting person. |
| 09/25/2025 | Signature date of the reporting person's attorney-in-fact for the filing. |
| 12/08/2025 | Vesting date for 3,070 RSUs from the 12/08/2022 grant. |
| 12/07/2025 | Vesting date for 5,687 RSUs from the 12/07/2023 grant. |
| 12/09/2025 | Vesting date for 39,665 RSUs from the 12/09/2024 grant. |
Keywords
HPE, Hewlett Packard Enterprise, Insider Transaction, Form 4, Stock Sale, Restricted Stock Units, RSU, Executive Compensation, Maeve C. Culloty
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.